157 related articles for article (PubMed ID: 33455308)
21. Poly(caprolactone)-modified Pluronic P105 micelles for reversal of paclitaxcel-resistance in SKOV-3 tumors.
Wang Y; Hao J; Li Y; Zhang Z; Sha X; Han L; Fang X
Biomaterials; 2012 Jun; 33(18):4741-51. PubMed ID: 22445254
[TBL] [Abstract][Full Text] [Related]
22. Targeted paclitaxel nanoparticles modified with follicle-stimulating hormone β 81-95 peptide show effective antitumor activity against ovarian carcinoma.
Zhang X; Chen J; Kang Y; Hong S; Zheng Y; Sun H; Xu C
Int J Pharm; 2013 Sep; 453(2):498-505. PubMed ID: 23811008
[TBL] [Abstract][Full Text] [Related]
23. Paclitaxel and di-fluorinated curcumin loaded in albumin nanoparticles for targeted synergistic combination therapy of ovarian and cervical cancers.
Gawde KA; Sau S; Tatiparti K; Kashaw SK; Mehrmohammadi M; Azmi AS; Iyer AK
Colloids Surf B Biointerfaces; 2018 Jul; 167():8-19. PubMed ID: 29625422
[TBL] [Abstract][Full Text] [Related]
24. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
25. Development and evaluation of a novel TPGS-mediated paclitaxel-loaded PLGA-mPEG nanoparticle for the treatment of ovarian cancer.
Lv W; Cheng L; Li B
Chem Pharm Bull (Tokyo); 2015; 63(2):68-74. PubMed ID: 25451039
[TBL] [Abstract][Full Text] [Related]
26. Combinational phototherapy and hypoxia-activated chemotherapy favoring antitumor immune responses.
Ma B; Sheng J; Wang P; Jiang Z; Borrathybay E
Int J Nanomedicine; 2019; 14():4541-4558. PubMed ID: 31417257
[No Abstract] [Full Text] [Related]
27. Novel Nano-Therapeutic Approach Actively Targets Human Ovarian Cancer Stem Cells after Xenograft into Nude Mice.
Abou-ElNaga A; Mutawa G; El-Sherbiny IM; Abd-ElGhaffar H; Allam AA; Ajarem J; Mousa SA
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417924
[TBL] [Abstract][Full Text] [Related]
28. Galactose-decorated cross-linked biodegradable poly(ethylene glycol)-b-poly(ε-caprolactone) block copolymer micelles for enhanced hepatoma-targeting delivery of paclitaxel.
Yang R; Meng F; Ma S; Huang F; Liu H; Zhong Z
Biomacromolecules; 2011 Aug; 12(8):3047-55. PubMed ID: 21726090
[TBL] [Abstract][Full Text] [Related]
29. Paclitaxel/tetrandrine coloaded nanoparticles effectively promote the apoptosis of gastric cancer cells based on "oxidation therapy".
Li X; Lu X; Xu H; Zhu Z; Yin H; Qian X; Li R; Jiang X; Liu B
Mol Pharm; 2012 Feb; 9(2):222-9. PubMed ID: 22171565
[TBL] [Abstract][Full Text] [Related]
30. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
[TBL] [Abstract][Full Text] [Related]
31. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature.
Yu DH; Lu Q; Xie J; Fang C; Chen HZ
Biomaterials; 2010 Mar; 31(8):2278-92. PubMed ID: 20053444
[TBL] [Abstract][Full Text] [Related]
32. Evaluations of combination MDR-1 gene silencing and paclitaxel administration in biodegradable polymeric nanoparticle formulations to overcome multidrug resistance in cancer cells.
Yadav S; van Vlerken LE; Little SR; Amiji MM
Cancer Chemother Pharmacol; 2009 Mar; 63(4):711-22. PubMed ID: 18618115
[TBL] [Abstract][Full Text] [Related]
33. Paclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(epsilon-caprolactone) nanoparticles: preparation and antitumor activity in vivo.
Zhu Z; Li Y; Li X; Li R; Jia Z; Liu B; Guo W; Wu W; Jiang X
J Control Release; 2010 Mar; 142(3):438-46. PubMed ID: 19896997
[TBL] [Abstract][Full Text] [Related]
34. Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer.
Xing L; Shi Q; Zheng K; Shen M; Ma J; Li F; Liu Y; Lin L; Tu W; Duan Y; Du L
Theranostics; 2016; 6(10):1573-87. PubMed ID: 27446491
[TBL] [Abstract][Full Text] [Related]
35. Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery.
Song N; Liu W; Tu Q; Liu R; Zhang Y; Wang J
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):454-63. PubMed ID: 21719259
[TBL] [Abstract][Full Text] [Related]
36. Preparation and biological evaluation of paclitaxel loaded biodegradable PCL/PEG nanoparticles for the treatment of human neuroendocrine pancreatic tumor in mice.
Dubey N; Shukla J; Hazari PP; Varshney R; Ganeshpurkar A; Mishra AK; Trivedi P; Bandopadhaya GP
Hell J Nucl Med; 2012; 15(1):9-15. PubMed ID: 22413106
[TBL] [Abstract][Full Text] [Related]
37. Supramolecular hydrogel based on high-solid-content mPECT nanoparticles and cyclodextrins for local and sustained drug delivery.
Yin L; Xu S; Feng Z; Deng H; Zhang J; Gao H; Deng L; Tang H; Dong A
Biomater Sci; 2017 Mar; 5(4):698-706. PubMed ID: 28184404
[TBL] [Abstract][Full Text] [Related]
38. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells.
Nag M; Gajbhiye V; Kesharwani P; Jain NK
Colloids Surf B Biointerfaces; 2016 Dec; 148():363-370. PubMed ID: 27632697
[TBL] [Abstract][Full Text] [Related]
39. Development of redox-responsive theranostic nanoparticles for near-infrared fluorescence imaging-guided photodynamic/chemotherapy of tumor.
Yang X; Shi X; Ji J; Zhai G
Drug Deliv; 2018 Nov; 25(1):780-796. PubMed ID: 29542333
[TBL] [Abstract][Full Text] [Related]
40. Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study.
Cabeza L; Ortiz R; Prados J; Delgado ÁV; Martín-Villena MJ; Clares B; Perazzoli G; Entrena JM; Melguizo C; Arias JL
Eur J Pharm Sci; 2017 May; 102():24-34. PubMed ID: 28219748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
